GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hybio Pharmaceutical Co Ltd (SZSE:300199) » Definitions » Cyclically Adjusted PB Ratio

Hybio Pharmaceutical Co (SZSE:300199) Cyclically Adjusted PB Ratio : 5.47 (As of Jun. 05, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Hybio Pharmaceutical Co Cyclically Adjusted PB Ratio?

As of today (2025-06-05), Hybio Pharmaceutical Co's current share price is ¥14.54. Hybio Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ¥2.66. Hybio Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is 5.47.

The historical rank and industry rank for Hybio Pharmaceutical Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

SZSE:300199' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.6   Med: 3.66   Max: 8.03
Current: 5.36

During the past years, Hybio Pharmaceutical Co's highest Cyclically Adjusted PB Ratio was 8.03. The lowest was 1.60. And the median was 3.66.

SZSE:300199's Cyclically Adjusted PB Ratio is ranked worse than
83.93% of 703 companies
in the Drug Manufacturers industry
Industry Median: 1.97 vs SZSE:300199: 5.36

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Hybio Pharmaceutical Co's adjusted book value per share data for the three months ended in Mar. 2025 was ¥0.734. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥2.66 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hybio Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Hybio Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hybio Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Hybio Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.44 4.51 6.16 4.83 4.74

Hybio Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.34 3.92 4.31 4.74 5.88

Competitive Comparison of Hybio Pharmaceutical Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Hybio Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hybio Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hybio Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Hybio Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


;
;

Hybio Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Hybio Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=14.54/2.66
=5.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hybio Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Hybio Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.734/115.1156*115.1156
=0.734

Current CPI (Mar. 2025) = 115.1156.

Hybio Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201506 2.708 99.500 3.133
201509 2.811 100.500 3.220
201512 2.963 100.600 3.391
201603 3.048 102.200 3.433
201606 3.102 101.400 3.522
201609 3.841 102.400 4.318
201612 3.925 102.600 4.404
201703 4.008 103.200 4.471
201706 3.941 103.100 4.400
201709 4.009 104.100 4.433
201712 4.156 104.500 4.578
201803 4.237 105.300 4.632
201806 4.189 104.900 4.597
201809 4.327 106.600 4.673
201812 3.653 106.500 3.949
201903 3.464 107.700 3.703
201906 3.442 107.700 3.679
201909 3.334 109.800 3.495
201912 2.430 111.200 2.516
202003 2.475 112.300 2.537
202006 2.502 110.400 2.609
202009 2.481 111.700 2.557
202012 1.786 111.500 1.844
202103 1.818 112.662 1.858
202106 1.760 111.769 1.813
202109 1.667 112.215 1.710
202112 1.728 113.108 1.759
202203 1.698 114.335 1.710
202206 1.668 114.558 1.676
202209 1.632 115.339 1.629
202212 1.386 115.116 1.386
202303 1.472 115.116 1.472
202306 1.428 114.558 1.435
202309 1.273 115.339 1.271
202312 0.859 114.781 0.862
202403 0.847 115.227 0.846
202406 0.854 114.781 0.856
202409 0.800 115.785 0.795
202412 0.655 114.893 0.656
202503 0.734 115.116 0.734

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hybio Pharmaceutical Co  (SZSE:300199) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Hybio Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Hybio Pharmaceutical Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hybio Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
4th Floor, Office Building, Hanyu Biomedical Park, Middle District, High-tech Industrial Park, Nanshan District, Guangdong Province, Shenzhen, CHN, 518057
Hybio Pharmaceutical Co Ltd is engaged in manufacturing and sale of peptide products. The company's peptide finished dosage products include digestive system agents, immune modulators, hormone and endocrine modulators, antiviral agents, and hemostatic products. It also provides peptide CRO and CMO services, as well as API products.
Executives
Ceng Shao Gui Director
Ceng Shao Bin Director
Ceng Shao Qiang Director
Zhu Wen Feng Directors, Directors, and Executives
Tao An Jin Executives
Wei Hong Executives
Yuan Jian Cheng Directors, executives
Liu Jian Executives
Yang Jun Executives
Executives
Zhu Ning Supervisors
Yang Chun Hai Supervisors
Cai Lei Directors, executives

Hybio Pharmaceutical Co Headlines

No Headlines